Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Paradigm innovation and theoretical breakthroughs in research of TCM compound drugs from modular pharmacology perspective].

Created on 18 Nov 2026

Authors

Jun Liu, Ya-Nan Yu, Bing Li, Ying-Ying Zhang, Zhong Wang

Published in

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. Volume 51. Issue 20. Pages 5984-5990.

Abstract

Modular Pharmacology(MP) adopts the ontological principle that "a module is a functional unit" and replaces traditional static descriptions of single targets or holistic networks. With a modular deconstruction of complex biological systems, a new paradigm for TCM pharmacological research has been constructed, spanning mechanism analysis to the discovery of new compound drugs. Since its conceptualization in 2013, MP has matured into a cutting-edge interdisciplinary field characterized by a robust theoretical architecture, standardized technical methodologies, and broad applications. This paper systematically reviewed the discipline's significant progress in theoretical breakthroughs, technological innovations, and industrial applications, highlighting the establishment of MP theory guided by network-based Xiang-Shu thinking. It further delineated a complete technical system encompassing molecular target module identification, quantitative analysis of module allostery, module-based synchronous cooperative control, and targeted module reorganization and optimization. It also presented calculable, verifiable, and interpretable systematic advantages in analyzing the compatibility mechanism of TCM compounds, screening new TCM drugs, and achieving precise clinical positioning of compounds. In the future, to transition MP from an explanatory framework to a tool for prediction design, it is essential to deeply integrate the MP and technologies such as explainable artificial intelligence(AI), panoramic omics, digital twins, and biomanufacturing. Collectively, these advancements will drive a revolutionary transformation in TCM compound drug research, shifting from experience-driven research to predictive design, thereby providing the scientific foundation for the precision and international development of TCM compound drugs.

PMID:
43045139
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement